Operating
Change in Long-term Tax Liabilities
Amgen Change in Long-term Tax Liabilities decreased by 5.3% to $71.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.4%, from $70.00M to $71.00M. Over 2 years (FY 2022 to FY 2025), Change in Long-term Tax Liabilities shows an upward trend with a 16.5% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryRisk
SignalContext dependent
VolatilityStable
First reportedQ1 2015
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase suggests a rise in long-term tax deferrals, while a decrease indicates the resolution or payment of long-term tax liabilities.
Detailed definition
This metric captures the net change in non-current tax obligations, such as deferred tax liabilities or long-term unreco...
Peer comparison
Specific to large multinationals with complex tax structures; peers in biotech often report similar long-term tax accruals.
Metric ID:
amgn_change_in_long_term_tax_liabilitiesHistorical Data
16 periods
| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $55.00M | $102.00M | $57.00M | $51.00M | $77.00M | $44.00M | $107.00M | $89.00M | $97.00M | $78.00M | -$715.00M | $70.00M | $92.00M | $74.00M | $75.00M | $71.00M |
| QoQ Change | — | +85.5% | -44.1% | -10.5% | +51.0% | -42.9% | +143.2% | -16.8% | +9.0% | -19.6% | <-999% | +109.8% | +31.4% | -19.6% | +1.4% | -5.3% |
| YoY Change | — | — | — | — | +40.0% | -56.9% | +87.7% | +74.5% | +26.0% | +77.3% | -768.2% | +109.8% | — | — | — | +1.4% |
Range-$715.00M – $107.00M
CAGR+7.0%
Avg YoY Growth-45.4%
Median YoY Growth+40.0%
Change in Long-term Tax Liabilities at Other Companies
Frequently Asked Questions
- What is Amgen's change in long-term tax liabilities?
- Amgen (AMGN) reported change in long-term tax liabilities of $71.00M in Q1 2026.
- How has Amgen's change in long-term tax liabilities changed year-over-year?
- Amgen's change in long-term tax liabilities increased by 1.4% year-over-year, from $70.00M to $71.00M.
- What is the long-term trend for Amgen's change in long-term tax liabilities?
- Over 2 years (2022 to 2025), Amgen's change in long-term tax liabilities has grown at a 16.5% compound annual growth rate (CAGR), from $229.00M to $311.00M.
- What does change in long-term tax liabilities mean?
- The net change in long-term tax-related debt or obligations.